Kaleido Biosciences Stock Target Price and Analyst Consensus

KLDO -  USA Stock  

USD 5.78  0.11  1.94%

The current analyst and expert consensus on Kaleido Biosciences is Hold, with 1 strong sell and 3 strong buy opinions. The current projected Kaleido Biosciences target price consensus is 14.6 with 5 analyst opinions. The most common way Kaleido Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Kaleido Biosciences executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Kaleido Biosciences. We strongly encourage you to use your own analysis of Kaleido Biosciences to validate this buy or sell advice. Kaleido Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Kaleido Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 6.58. Please see Macroaxis Advice on Kaleido Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Search Analyst Recommendations 

The value of Gross Profit is estimated to slide to about 872.4 K. The value of Profit Margin is estimated to slide to -81.29. Kaleido Biosciences Shareholders Equity is quite stable at the moment as compared to the past year. The company's current value of Shareholders Equity is estimated at 22.11 Million. Liabilities Non Current is expected to rise to about 23.3 M this year, although the value of Assets Non Current will most likely fall to about 10.1 M.

Kaleido Biosciences Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kaleido target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kaleido target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions5
Lowered Outlook0
Raized Outlook0
Most Kaleido analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Kaleido stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Kaleido Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Kaleido Biosciences Target Price Projection

Kaleido Biosciences' current and average target prices are 5.78 and 14.60, respectively. The current price of Kaleido Biosciences is the price at which Kaleido Biosciences is currently trading. On the other hand, Kaleido Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Kaleido Biosciences Market Quote on 4th of August 2021

Low Price5.65Odds
High Price6.0Odds


Target Price

Analyst Consensus On Kaleido Biosciences Target Price

Low Estimate5.0Odds
High Estimate22.0Odds
Number of Analysts5
Standard Deviation6.58


Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Kaleido Biosciences and the information provided on this page.

Kaleido Biosciences Analyst Ratings

Kaleido Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Kaleido Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Kaleido Biosciences' financials, market performance, and future outlook by experienced professionals. Kaleido Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Kaleido Biosciences Target Price Projections

Kaleido Biosciences's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Kaleido Biosciences and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Kaleido depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Kaleido Biosciences

Additional Kaleido Biosciences Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Kaleido Biosciences is a key component of Kaleido Biosciences valuation and have some predictive power on the future returns of a Kaleido Biosciences.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Kaleido Biosciences in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
Estimates (4)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kaleido Biosciences. Your research has to be compared to or analyzed against Kaleido Biosciences' peers to derive any actionable benefits. When done correctly, Kaleido Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Kaleido Biosciences.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Artificial Intelligence
Invested one share
Social Domain
Invested one share
Macroaxis Index
Invested over 100 shares
Please see Macroaxis Advice on Kaleido Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
The data published in Kaleido Biosciences' official financial statements usually reflect Kaleido Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Kaleido Biosciences. For example, before you start analyzing numbers published by Kaleido accountants, it's critical to develop an understanding of what Kaleido Biosciences' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Kaleido Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kaleido Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Kaleido Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kaleido Biosciences. Please utilize our Beneish M Score to check the likelihood of Kaleido Biosciences' management to manipulate its earnings.